Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.0)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2013, vol. 22, nr 6, November-December, p. 809–815

Publication type: original article

Language: English

Positive Airway Pressure Device Compliance of the Patients with Obstructive Sleep Apnea Syndrome

Wspomaganie oddechu stałym dodatnim ciśnieniem u chorych na obturacyjny bezdech senny

Haşim Boyacı1,A, Kübra Gacar2,B,C, Serap Argun Barış1,D, Ilknur Başyiğit1,E, Füsun Yıldız1,F

1 Department of Pulmonary Disease, Kocaeli University, Medical Faculty, Turkey

2 Department of Pulmonary Disease, Sakarya Yenikent Government Hospital, Turkey

Abstract

Objectives. The aim of this study was to evaluate factors affecting the usage of continuous positive airway pressure (CPAP) device in patients with obstructive sleep apnea syndrome (OSAS).
Material and Methods. This study included 47 patients with OSAS who were suggested to use CPAP device at home and expected to use the device for at least 6 months. The compliance of CPAP device was determined by 2 different methods. In subjective evaluation, total time for usage of the device was recorded according to patients’ declaration. In objective evaluation, total time of usage was recorded from the counter on device and it was divided into the number of days passed from the beginning of the treatment and at least 4 h of usage in a day was accepted as an effective usage. Data of compliant and non-compliant patients were compared in order to determine the factors affecting CPAP treatment.
Results. Ten patients were female, 37 of them were male and mean age was 52.98 ± 20.4 years. Mean Apnea Hypopnea Index (AHI) was 54.4 ± 20, mean oxygen saturation (SO2) was 87.3 ± 4.6 and mean CPAP pressure was 7.4 ± 1.9 in the whole study population. The compliance of CPAP treatment was found to be 48.9% according to objective evaluation whereas it was 80.9% according to subjective evaluation. Five of 8 patients (62.5%) who did not use the device stated the problems about the device mentioning the mask as a reason for their non-compliance. Treatment compliance was better in the patients with high Epworth sleepiness scale (16.5 ± 5.5 vs. 11.8 ± 4.1, p < 0.05). Epworth sleepiness scale of the patients who were compliant to the treatment was significantly decreased after the treatment both in subjective and objective evaluation. Treatment compliance wasn’t different between male and female patients, however it was significantly lower in active smokers compared to non-smokers and ex-smokers.
Conclusion. It was concluded that the most important factor associated with compliance to CPAP treatment in the patients with OSAS was Epworth sleepiness scale while mask related side effects might be a reason of treatment withdrawal and all these issues should be addressed carefully in order to increase compliance

Key words

OSAS, CPAP treatment, compliance.

References (34)

  1. Olson EJ, Park JG, Morgenthaler TI: Obstructive sleep apnea hypopnea syndrome. Prim Care 2005, 32, 329–359.
  2. Park JG, Ramar K, Olson EJ: Updates on definition, consequences, and management of obstructive sleep apnea: Mayo Clin Proc 2011, 86, 549–554.
  3. Loube DI, Gay PC, Strohl KP, Pack Al, White DP, Collop NA: Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999, 115, 863–866.
  4. Vitulano N, Di Marco Berardino A, Re A, Riccioni G, Perna F, Mormile F, Valente S, Belocci F: Obstructive sleep apnea and heart disease: the biomarkers point of view. Front Biosci (Schol Ed) 2013, 1, 588–599.
  5. Doherty LS, Kiely JL, Swan V, Mc Nicholas WT: Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127, 2076–2084.
  6. Weaver TE, Grunstein RR: Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008, 5, 173–178.
  7. Gay P, Weaver T, Loube D, Iber C: Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006, 29, 381–401.
  8. Rauscher H, Formanek D, Popp W, Zwick H: Self-reported vs. measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993, 103, 1675–1680.
  9. Meurice JC, Dore P, Paquereau J, Neau JP, Ingrand P, Chavagnat JJ, Patte F: Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994, 105, 429–433.
  10. Hui DS, Choy DK, Li TS, Ko FW, Wong KK, Chan JK, Lai CK: Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 2001, 120, 170–176.
  11. Russo-Magno P, O’Brien A, Panciera T, Rounds S: Compliance with CPAP therapy in older men with obstructive sleep apnea. J Am Geriatr Soc 2001, 49, 1205–1211.
  12. Sin DD, Mayers I, Man GC, Pawluk L: Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002, 121, 430–435.
  13. Lindberg E, Berne C, Elmasry A, Hedner J, Janson C: CPAP treatment of a population-based sample: what are the benefits and the treatment compliance? Sleep Med 2006, 7, 553–560.
  14. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ: Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006, 29, 1036–1044.
  15. Parthasarathy S, Haynes PL, Budhiraja R, Habib MP, Quan SF: A national survey of the effect of sleep medicine specialists and American Academy of Sleep Medicine Accreditation on management of obstructive sleep apnea. J Clin Sleep Med 2006, 2, 133–142.
  16. Chasens ER, Pack AI, Maislin G, Dinges DF, Weaver TE: Claustrophobia and adherence to CPAP treatment. West J Nurs Res 2005, 27, 307–321.
  17. Amfilochiou A, Tsara V, Kolilekas L, Gizopoulou E, Maniou C, Bouros D, Polychronopoulos V: Determinants of continuous positive airway pressure compliance in a group of Greek patients with obstructive sleep apnea. Eur J Intern Med 2009, 20, 645–650.
  18. Reeves-Hoche MK, Meck R, Zwillich CW: Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994, 149, 149–154.
  19. Engleman H, Asgari-Jirhandeh N, Mc Leod AL, Ramsay CF, Deary IJ, Douglas NJ: Self reported use of CPAP and benefits of CPAP therapy. Chest 1996, 109, 1470–1476.
  20. Rauscher H, Formanek D, Popp W, Zwick H: Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993, 103, 1675–1680.
  21. WHO, prevention and management of global epidemic obesity. Report of WHO consultation on obesity 1997, Genova.
  22. Nieto FJ, Young TB, Lind BK, Sharar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG: Association of sleep-disordered breathing, sleep apnea, and hypertension in large community based study. JAMA 2000, 283, 1829–1836.
  23. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ: Long-term use of PAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159, 1108–1114.
  24. Young T, Finn L, Austin D, Peterson A: Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003, 167, 1181–1185.
  25. Lin HS, Prasad AS, Pan CJ, Rowley JA: Factors associated with noncompliance to treatment with positive airway pressure. Arch Otolaryngol Head Neck Surg 2007, 133, 69–72.
  26. Uyar M, Elbek O, Mete A, Bayram N, Çiftçi N, Gündoğdu N, Dikensoy Ö: Factors influencing compliance with continuous positive airway pressure ventilation in obstructive sleep apnea syndrome. Tub Toraks 2012, 60, 47–51.
  27. Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, Monasterio C, Bosch M, Ladaria A, Rubio M, Rubio R, Medinas M, Hernandez L, Vidal S, Douglas NJ, Agusti AG: Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Ann Intern Med 2001, 134, 1015–1023.
  28. Yetkin O, Kunter E, Gunen H: PAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath 2008, 12, 365–367.
  29. Galetke W, Puzzo L, Priegnitz C, Anduleit N, Randerath WJ: Long-term therapy with continuous positive airway pressure in obstructive sleep apnea: Adherence, side effects and predictors of withdrawal – a real life study. Respiration 2011, 82, 155–161.
  30. Sullivan CE, İssa FG, Berthon-Jones M, Eves L: Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981, 1, 862–865.
  31. Sopkova Z, Dorkova Z, Tkacova R: Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009, 121, 398–404.
  32. Waldhorn RE, Herrick TW, Nguyen MC, O’Donnell AE, Sodero J, Potolicchio SJ: Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990, 97, 33–38.
  33. Weaver TE: Adherence to positive airway pressure therapy. Curr Opin Pulm Med 2006, 12, 409–413.
  34. Gülcü A, İtil O, Öztura I,Sener G, Sahbaz S, Sevinç C, Kılınç O, İkiz AÖ, Çımrın AH, Uçan ES, Akkoçlu A: Compliance, side effects and results of PAP therapy in cases with obstructive sleep apnea syndrome. Turkish Resp J 2005, 3, 135–138.
© Wroclaw Medical University